In Vitro assessment of the utility of stearyl triphenyl phosphonium modified liposomes in overcoming the resistance of ovarian carcinoma Ovcar-3 cells to paclitaxel

Targeting multidrug resistance in cancer

Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609 · see citing works

Promotion of microtubule assembly in vitro by taxol

SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600 · see citing works

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009

Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.150 · Cited by 3,399 · see citing works

Pyroptosis: host cell death and inflammation

Bergsbaken, T., Fink, S. L., & Cookson, B. T. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2070 · Cited by 3,185 · see citing works

Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.

Jordan, M. A., Toso, R. J., Thrower, D., & Wilson, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9552 · Cited by 1,095 · see citing works

Mechanisms of Multidrug Resistance in Cancer

Gillet, J., & Gottesman, M. M. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 696 · see citing works

Cisplatin-Induced Renal Cell Apoptosis: Caspase 3-Dependent and -Independent Pathways

Cummings, B. S., & Schnellmann, R. G. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.8 · Cited by 358 · see citing works

Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation

Yusuf, R., Duan, Z., Lamendola, D. E., Penson, R. T., & Seiden, M. V. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033333754 · Cited by 356 · see citing works

Do inducers of apoptosis trigger caspase-independent cell death?

Chipuk, J. E., & Green, D. R. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1573 · Cited by 312 · see citing works

Acquired multicellular-mediated resistance to alkylating agents in cancer.

Kobayashi, H., Man, S., Graham, C. H., Kapitain, S. J., Teicher, B. A., & Kerbel, R. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3294 · Cited by 277 · see citing works

Drug and radiation resistance in spheroids: cell contact and kinetics

Olive, P. L., & Durand, R. E. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689632 · Cited by 271 · see citing works

3'-(p-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of beta-tubulin.

Rao, S. P. S., Krauss, N. E., Heerding, J. M., Swindell, C. S., Ringel, I., Orr, G. A., & Horwitz, S. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41836-9 · Cited by 245 · see citing works

Characterization of the Taxol Binding Site on the Microtubule

Rao, S. P. S., Orr, G. A., Chaudhary, A., Kingston, D. G. I., & Horwitz, S. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20235 · Cited by 236 · see citing works

Organelle-Targeted Nanocarriers: Specific Delivery of Liposomal Ceramide to Mitochondria Enhances Its Cytotoxicity in Vitro and in Vivo

Boddapati, S. V., D’Souza, G. G. M., Erdoğan, S., Torchilin, V. P., & Weissig, V. (2008) · Nano Letters · doi:10.1021/nl801908y · Cited by 234 · see citing works

Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin

Minotti, A., Barlow, S. B., & Cabral, F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67891-9 · Cited by 222 · see citing works

Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor

Kunz‐Schughart, L. A. (1999) · Cell Biology International · doi:10.1006/cbir.1999.0384 · Cited by 217 · see citing works

Modulation of Intracellular Ceramide Using Polymeric Nanoparticles to Overcome Multidrug Resistance in Cancer

van Vlerken, L. E., Duan, Z., Seiden, M. V., & Amiji, M. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1648 · Cited by 214 · see citing works

Nilotinib (AMN107, Tasigna®) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters

Tiwari, A. K., Sodani, K. S., Wang, S., Kuang, Y., Ashby, C. R., Chen, X. '., & Chen, Z. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.002 · Cited by 210 · see citing works

Mitochondria as targets for detection and treatment of cancer

Modica-Napolitano, J. S., & Singh, K. K. (2002) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399402004453 · Cited by 205 · see citing works

Mitochondria in cancer

Kroemer, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209589 · Cited by 201 · see citing works

Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells'.

André, N., Braguer, D., Brasseur, G., Gonçalvès, A., Lemesle-Meunier, D., Guise, S., Jordan, M. A., & Briand, C. M. (2000) · PubMed · Cited by 178 · see citing works

Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference

Ward, M. H., Sinha, R. R., Heineman, E. F., Rothman, N., Markin, R. S., Weisenburger, D. D., Correa, P., & Zahm, S. H. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970328)71:1 · Cited by 176 · see citing works

Growth and Cellular Characteristics of Multicell Spheroids

Sutherland, R. M., & Durand, R. E. (1984) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-82340-4_2 · Cited by 167 · see citing works

Recent Advances on the Molecular Mechanisms Involved in the Drug Resistance of Cancer Cells and Novel Targeting Therapies

Mimeault, M., Hauke, R. J., & Batra, S. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100296 · Cited by 166 · see citing works

Cancer multidrug resistance: a review of recent drug discovery research.

Liscovitch, M., & Lavie, Y. (2002) · PubMed · Cited by 134 · see citing works

Mitochondriotropic Liposomes

Boddapati, S. V., Tongcharoensirikul, P., Hanson, R. N., D’Souza, G. G. M., Torchilin, V. P., & Weissig, V. (2005) · Journal of Liposome Research · doi:10.1081/lpr-64958 · Cited by 129 · see citing works

Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel

Liu, C., Zhao, G., Liu, J., Ma, N., Chivukula, P., Perelman, L. A., Okada, K., Chen, Z., Gough, D., & Yu, L. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.013 · Cited by 122 · see citing works

Modulation of Drug Resistance in Ovarian Adenocarcinoma by Enhancing Intracellular Ceramide Using Tamoxifen-Loaded Biodegradable Polymeric Nanoparticles

Devalapally, H., Duan, Z., Seiden, M. V., & Amiji, M. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4973 · Cited by 121 · see citing works

Proliferation and viability in cellular spheroids of human origin.

Haji-Karim, M., & Carlsson, J. (1978) · PubMed · Cited by 107 · see citing works

Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures

Lang, S., SHARRARD, R. M., Stark, M., Villette, J. M., & Maitland, N. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1967 · Cited by 106 · see citing works

Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance

Kuang, Y., Shen, T., Chen, X. '., Sodani, K. S., Hopper-Borge, E. A., Tiwari, A. K., Lee, J. W. K. K., Fu, L., & Chen, Z. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.021 · Cited by 99 · see citing works

Isolation of a taxol-resistant Chinese hamster ovary cell mutant that has an alteration in alpha-tubulin.

Cabral, F., Abraham, I., & Gottesman, M. M. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4388 · Cited by 93 · see citing works

Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents.

Nicoletti, M. I., Valoti, G., Giannakakou, P., Zhan, Z., Kim, J. H., Lucchini, V., Landoni, F., Mayo, J. G., Giavazzi, R., & Fojo, T. (2001) · PubMed · Cited by 85 · see citing works

Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol

Patel, N. R., Hatziantoniou, S., Georgopoulos, A., Demetzos, C., Torchilin, V. P., Weissig, V., & D’Souza, G. G. M. (2009) · Journal of Liposome Research · doi:10.3109/08982100903347931 · Cited by 81 · see citing works

Nanocarrier-assisted sub-cellular targeting to the site of mitochondria improves the pro-apoptotic activity of paclitaxel

D’Souza, G. G. M., Cheng, S.-M., Boddapati, S. V., Horobin, R. W., & Weissig, V. (2008) · Journal of drug targeting · doi:10.1080/10611860802228855 · Cited by 80 · see citing works

Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer

Matsuoka (1992) · International Journal of Oncology · doi:10.3892/ijo_00000153 · Cited by 74 · see citing works

A Mechanism of Cellular Resistance to Drugs that Interfere with Microtubule Assemblya

Cabral, F. R., Brady, R. C., & Schibler, M. J. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb38456.x · Cited by 72 · see citing works

Characterization of a Taxol‐resistant Human Small‐cell Lung Cancer Cell Line

Ohta, S., Nishio, K., Kubota, N., Ohmori, T., Funayama, Y., Ohira, T., Nakajima, H., Adachi, M., & Saijo, N. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02096.x · Cited by 67 · see citing works

Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non‐tumorigenic and tumorigenic cells in vitro

Pantazis, P., Kozielski, A. J., Mendoza, J. T., Early, J., Hinz, H. R., & Giovanella, B. C. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530526 · Cited by 58 · see citing works

Sipholane Triterpenoids: Chemistry, Reversal of ABCB1/P-Glycoprotein-Mediated Multidrug Resistance, and Pharmacophore Modeling

Jain, S. K., Abraham, I., de Carvalho, P. B., Kuang, Y., Shaala, L. A., Youssef, D. T. A., Avery, M. A., Chen, Z., & Sayed, K. A. E. (2009) · Journal of Natural Products · doi:10.1021/np900091y · Cited by 56 · see citing works

Altered Oral Bioavailability and Pharmacokinetics of P-Glycoprotein Substrates by Coadministration of Biochanin A

Peng, S. X., Ritchie, D. M., Cousineau, M., Danser, E., DeWire, R., & Floden, J. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20664 · Cited by 49 · see citing works

Inhibition of P‐Glycoprotein by Wogonin Is Involved with the Potentiation of Etoposide‐Induced Apoptosis in Cancer Cells

Lee, E., Enomoto, R., Koshiba, C., & Hirano, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04722.x · Cited by 43 · see citing works

Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer

田淵, 陽. (2009) · Institutional Repositories DataBase (IRDB) · Cited by 40 · see citing works

Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs

Sun, Y., Zhang, T., Gao, P., Meng, B., Gao, Y., Wang, X., Zhang, J., Wang, H., Wu, X., Zheng, W., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0513-z · Cited by 30 · see citing works

Paclitaxel C-10 carbamates: Potential candidates for the treatment of neurodegenerative tauopathies

Ballatore, C., Hyde, E. G., Deiches, R. F., Lee, V. M. ‐., Trojanowski, J. Q., Huryn, D. M., & Smith, A. B. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.04.058 · Cited by 19 · see citing works

Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications

Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683 · see citing works

ROS-Responsive Mitochondria-Targeting Blended Nanoparticles: Chemo- and Photodynamic Synergistic Therapy for Lung Cancer with On-Demand Drug Release upon Irradiation with a Single Light Source

Yue, C., Yang, Y., Zhang, C., Alfranca, G., Cheng, S., Ma, L., Liu, Y., Zhi, X., Ni, J., Jiang, W., et al. (2016) · Theranostics · doi:10.7150/thno.15433 · Cited by 169 · see citing works

Targeted nanoparticles in mitochondrial medicine

Pathak, R., Kolishetti, N., & Dhar, S. (2014) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1305 · Cited by 163 · see citing works

Mitochondria as a Novel Target for Cancer Chemoprevention: Emergence of Mitochondrial-targeting Agents

Huang, M., Myers, C. R., Wang, Y., & You, M. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0425 · Cited by 97 · see citing works

Triphenylphosphonium‐Conjugated Poly(ε‐caprolactone)‐Based Self‐Assembled Nanostructures as Nanosized Drugs and Drug Delivery Carriers for Mitochondria‐Targeting Synergistic Anticancer Drug Delivery

Cho, D. Y., Cho, H., Kwon, K., Yu, M., Lee, E. J., Huh, K. M., Lee, D. H., & Kang, H. C. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501422 · Cited by 93 · see citing works

From Broad-Spectrum Biocides to Quorum Sensing Disruptors and Mussel Repellents: Antifouling Profile of Alkyl Triphenylphosphonium Salts

Martín‐Rodríguez, A. J., Babarro, J. M. F., Lahoz, F. J., Sansón, M., Martı́n, V. S., Norte, M., & Fernández, J. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123652 · Cited by 91 · see citing works

Mitochondria-Targeting Particles

Wongrakpanich, A., Geary, S. M., Joiner, M.-L. A., Anderson, M. E., & Salem, A. K. (2014) · Nanomedicine · doi:10.2217/nnm.14.161 · Cited by 89 · see citing works

Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents

Modica-Napolitano, J. S., & Weissig, V. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817394 · Cited by 80 · see citing works

Design and Synthesis of Triphenylphosphonium Functionalized Nanoparticle Probe for Mitochondria Targeting and Imaging

Chakraborty, A., & Jana, N. R. (2015) · The Journal of Physical Chemistry C · doi:10.1021/jp511870e · Cited by 78 · see citing works

Triphenylphosphonium Decorated Liposomes and Dendritic Polymers: Prospective Second Generation Drug Delivery Systems for Targeting Mitochondria

Paleos, C. M., Tsiourvas, D., & Sideratou, Z. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00237 · Cited by 67 · see citing works

Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis

Shah, S., & D’Souza, G. G. M. (2025) · Cells · doi:10.3390/cells14100732 · Cited by 66 · see citing works

Triphenylphosphonium Cations of the Diterpenoid Isosteviol: Synthesis and Antimitotic Activity in a Sea Urchin Embryo Model

Strobykina, I. Y., Belenok, M. G., Semenova, M. N., Semenov, V. V., Babaev, V. M., Rizvanov, I. K., Mironov, V. F., & Kataev, V. E. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00124 · Cited by 60 · see citing works

Mitochondria Targeting Non-Isocyanate-Based Polyurethane Nanocapsules for Enzyme-Triggered Drug Release

Pramanik, S. K., Sreedharan, S., Singh, H., Khan, M., Tiwari, K., Shiras, A., Smythe, C., Thomas, J. A., & Das, A. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00460 · Cited by 58 · see citing works

Enhanced Subcellular Trafficking of Resveratrol Using Mitochondriotropic Liposomes in Cancer Cells

Kang, J. H., & Ko, Y. T. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11080423 · Cited by 56 · see citing works

Mitochondria-targeted cationic liposomes modified with alkyltriphenylphosphonium bromides loaded with hydrophilic drugs: preparation, cytotoxicity and colocalization assay

Kuznetsova, D. A., Gaynanova, G. A., Vasileva, L. A., Sibgatullina, G., Samigullin, D. V., Sapunova, А. S., Voloshina, A. D., Galkina, I. V., Petrov, K. A., & Zakharova, L. Y. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01853k · Cited by 56 · see citing works

Triphenylphosphonium-modified poly(ethylene glycol)-poly(ε-caprolactone) micelles for mitochondria- targeted gambogic acid delivery

Xu, Y., Wang, S., Chan, H. F., Liu, Y., Li, H., He, C., Li, Z., & Chen, M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.064 · Cited by 55 · see citing works

Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance

Han, X. F., Su, R., Huang, X., Wang, Y., Kuang, X., Zhou, S. Y., & Liu, H. (2018) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2018.06.006 · Cited by 55 · see citing works

Nanoscale drug delivery for taxanes based on the mechanism of multidrug resistance of cancer

Wang, S., Qiu, J.-G., Shi, Z., Wang, Y., & Chen, M. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.10.011 · Cited by 40 · see citing works

Emerging insights into mitochondria-specific targeting and drug delivering strategies: Recent milestones and therapeutic implications

Dhanasekaran, S., Venugopal, D., Al‐Dayan, N., Ravinayagam, V., & Mohammed, A. A. (2020) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2020.07.030 · Cited by 35 · see citing works

Targeted delivery of geranylgeranylacetone to mitochondria by triphenylphosphonium modified nanoparticles: a promising strategy to prevent aminoglycoside-induced hearing loss

Wang, Z., Kuang, X., Shi, J. D., Guo, W., & Liu, H. (2017) · Biomaterials Science · doi:10.1039/c7bm00224f · Cited by 31 · see citing works

Development of an<i>in vitro</i>tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics

Solomon, M. A., Lemera, J., & D’Souza, G. G. M. (2016) · Journal of Liposome Research · doi:10.3109/08982104.2015.1105820 · Cited by 30 · see citing works

Synergistic co-administration of docetaxel and curcumin to chemoresistant cancer cells using PEGylated and RIPL peptide-conjugated nanostructured lipid carriers

Kim, C. H., Kim, B. D., Lee, T. H., Kim, H. K., Lyu, M. J., Yoon, Y. I., Goo, Y. T., Kang, M. J., Lee, S. K., & Choi, Y. W. (2022) · Cancer Nanotechnology · doi:10.1186/s12645-022-00119-w · Cited by 30 · see citing works

Hydrophobized triphenyl phosphonium derivatives for the preparation of mitochondriotropic liposomes: choice of hydrophobic anchor influences cytotoxicity but not mitochondriotropic effect

Benien, P., Solomon, M. A., Nguyen, P., Sheehan, E., Mehanna, A. S., & D’Souza, G. G. M. (2015) · Journal of Liposome Research · doi:10.3109/08982104.2015.1022557 · Cited by 24 · see citing works

Triarylphosphonium compounds as effective vectors for mitochondria-targeted delivery systems: decoration strategies and prospects for clinical application

Pashirova, T. N., Nemtarev, A. V., Souto, E. B., & Mironov, V. F. (2023) · Russian Chemical Reviews · doi:10.59761/rcr5095 · Cited by 19 · see citing works

Mitochondria-Targeted Lipid Nanoparticles Loaded with Rotenone as a New Approach for the Treatment of Oncological Diseases

Vasileva, L. A., Gaynanova, G. A., Kuznetsova, D. A., Valeeva, F. G., Lyubina, A. P., Amerhanova, S. K., Voloshina, A. D., Sibgatullina, G., Samigullin, D. V., Petrov, K. A., et al. (2023) · Molecules · doi:10.3390/molecules28207229 · Cited by 14 · see citing works

Recent Developments in Phosphonium Chemistry

Berchel, M., & Jaffrès, P. (2019) · Organophosphorus chemistry · doi:10.1002/9783527672240.ch2 · Cited by 12 · see citing works

Synthesis of Triphenylphosphonium Phospholipid Conjugates for the Preparation of Mitochondriotropic Liposomes

Benein, P., Almuteri, M. A., Mehanna, A. S., & D’Souza, G. G. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2288-8_4 · Cited by 10 · see citing works

Targeted Drug Delivery to the Mitochondria

Agrawal, U., Sharma, R. K., & Vyas, S. P. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-11355-5_7 · Cited by 7 · see citing works

Lipid-Based Nanoparticles for Targeted Drug Delivery of Anticancer Drug

Shegokar, R., Athawale, R., Kurup, N., Yang, R., & Chougule, M. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809717-5.00011-7 · Cited by 6 · see citing works

In vitro assessment of stearyl triphenyl phosphonium toxicity in drug-resistant tumor cells

Shah, S., Ouellette, M., & D’Souza, G. G. M. (2022) · 4open · doi:10.1051/fopen/2022003 · Cited by 5 · see citing works

Determination of the Subcellular Distribution of Liposomes Using Confocal Microscopy

Solomon, M. A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6591-5_10 · Cited by 5 · see citing works

Synthesis of Triphenylphosphonium Phospholipid Conjugates for the Preparation of Mitochondriotropic Liposomes

Benien, P., Almuteri, M., Shah, S., Böhlke, M., Mehanna, A., & D’Souza, G. G. M. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1262-0_7 · Cited by 4 · see citing works

In vitro cytotoxicity of liposomal stearyl triphenyl phosphonium is influenced by mitochondrial bioenergetics

Shah, S., Gadde, R., Shukla, M., Tanna, H., Jadeja, P. P., Bhagwat, H., Joshi, R., Suluru, S., & D’Souza, G. G. M. (2025) · Journal of Liposome Research · doi:10.1080/08982104.2025.2567860 · Cited by 3 · see citing works

Triple co-culture spheroid models of lung and ovarian carcinoma cell lines for the in vitro testing of antitumor liposomes

Shah, S., Kim, Y., Pulak, R., & D’Souza, G. G. M. (2025) · Journal of Liposome Research · doi:10.1080/08982104.2025.2514850 · Cited by 3 · see citing works

Nanotechnology, mitochondria, and cancer

Wongrakpanich, A., Suksiriworapong, J., Geary, S. M., Sawangchan, P., Intra, J., Ruktanonchai, U., & Salem, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85666-9.00013-9 · Cited by 2 · see citing works

Determination of the Subcellular Distribution of Fluorescently Labeled Liposomes Using Confocal Microscopy

Solomon, M. A. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2954-3_24 · Cited by 1 · see citing works

Additional file 1 of Synergistic co-administration of docetaxel and curcumin to chemoresistant cancer cells using PEGylated and RIPL peptide-conjugated nanostructured lipid carriers

Kim, C. H., Kim, B. D., Lee, T. H., Kim, H. K., Lyu, M. J., Yoon, Y. I., Goo, Y. T., Kang, M. J., Lee, S., & Choi, Y. W. (2022) · Figshare · doi:10.6084/m9.figshare.20003481

La protéine Akt, lien entre mitochondries et microtubules dans le mécanisme d'action des agents anti-microtubules ou quand les MTA s'invitent dans de nouvelles stratégies thérapeutiques

Grand, M. L. (2015) · doi:10.70675/fa6f8780zf7dcz4aacz9c45z749a0a68559a

Current challenges in the development of liposomes to target mitochondria

Shah, S., & D’Souza, G. G. M. (2026) · Nanomedicine · doi:10.1080/17435889.2026.2658583

In vitro assessment of stearyl triphenyl phosphonium toxicity in drug-resistant tumor cells

Shah, S., Ouellette, M., & D’Souza, G. G. M. (2022) · 4open · doi:10.1051/fopen/2022003 · Cited by 5 · see citing works

In vitro cytotoxicity of liposomal stearyl triphenyl phosphonium is influenced by mitochondrial bioenergetics

Shah, S., Gadde, R., Shukla, M., Tanna, H., Jadeja, P. P., Bhagwat, H., Joshi, R., Suluru, S., & D’Souza, G. G. M. (2025) · Figshare · doi:10.6084/m9.figshare.30271797

Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo

Biswas, S., Dodwadkar, N. S., Deshpande, P. P., & Torchilin, V. P. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.009 · Cited by 281 · see citing works

Overcoming drug-resistant lung cancer by paclitaxel-loaded hyaluronic acid-coated liposomes targeted to mitochondria

Tian, Y., Zhang, H., Qin, Y., Li, D., Liu, Y., Wang, H., & Gan, L. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1512613 · Cited by 51 · see citing works

Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance

Han, X. F., Su, R., Huang, X., Wang, Y., Kuang, X., Zhou, S. Y., & Liu, H. (2018) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2018.06.006 · Cited by 55 · see citing works